TG Therapeutics Price to Sales Ratio 2010-2023 | TGTX
Historical PS ratio values for TG Therapeutics (TGTX) over the last 10 years. The current P/S ratio for TG Therapeutics as of May 03, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| TG Therapeutics P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-05-03 | 16.19 | 10.59 | |
| 2023-12-31 | 17.08 | $1.53 | 11.17 |
| 2023-09-30 | 8.36 | $1.23 | 6.78 |
| 2023-06-30 | 24.84 | $0.17 | 145.69 |
| 2023-03-31 | 15.04 | $0.06 | 245.30 |
| 2022-12-31 | 11.83 | $0.02 | 571.50 |
| 2022-09-30 | 5.92 | $0.04 | 157.21 |
| 2022-06-30 | 4.25 | $0.05 | 81.26 |
| 2022-03-31 | 9.51 | $0.06 | 159.59 |
| 2021-12-31 | 19.00 | $0.05 | 375.48 |
| 2021-09-30 | 33.28 | $0.03 | 997.08 |
| 2021-06-30 | 38.79 | $0.02 | 2112.91 |
| 2021-03-31 | 48.20 | $0.01 | 0.00 |
| 2020-12-31 | 52.02 | $0.00 | 0.00 |
| 2020-09-30 | 26.76 | $0.00 | 0.00 |
| 2020-06-30 | 19.48 | $0.00 | 0.00 |
| 2020-03-31 | 9.84 | $0.00 | 0.00 |
| 2019-12-31 | 11.10 | $0.00 | 0.00 |
| 2019-09-30 | 5.62 | $0.00 | 0.00 |
| 2019-06-30 | 8.65 | $0.00 | 0.00 |
| 2019-03-31 | 8.04 | $0.00 | 0.00 |
| 2018-12-31 | 4.10 | $0.00 | 0.00 |
| 2018-09-30 | 5.60 | $0.00 | 0.00 |
| 2018-06-30 | 13.15 | $0.00 | 0.00 |
| 2018-03-31 | 14.20 | $0.00 | 0.00 |
| 2017-12-31 | 8.20 | $0.00 | 0.00 |
| 2017-09-30 | 11.85 | $0.00 | 0.00 |
| 2017-06-30 | 10.05 | $0.00 | 0.00 |
| 2017-03-31 | 11.65 | $0.00 | 0.00 |
| 2016-12-31 | 4.65 | $0.00 | 0.00 |
| 2016-09-30 | 7.74 | $0.00 | 0.00 |
| 2016-06-30 | 6.06 | $0.00 | 0.00 |
| 2016-03-31 | 8.52 | $0.00 | 0.00 |
| 2015-12-31 | 11.93 | $0.00 | 0.00 |
| 2015-09-30 | 10.08 | $0.00 | 0.00 |
| 2015-06-30 | 16.59 | $0.00 | 0.00 |
| 2015-03-31 | 15.48 | $0.00 | 0.00 |
| 2014-12-31 | 15.84 | $0.00 | 0.00 |
| 2014-09-30 | 10.67 | $0.01 | 0.00 |
| 2014-06-30 | 9.39 | $0.01 | 0.00 |
| 2014-03-31 | 6.90 | $0.01 | 0.00 |
| 2013-12-31 | 3.90 | $0.01 | 0.00 |
| 2013-09-30 | 5.04 | $0.00 | 0.00 |
| 2013-06-30 | 6.39 | $0.00 | 0.00 |
| 2013-03-31 | 5.40 | $0.00 | 0.00 |
| 2012-12-31 | 3.64 | 0 | 0.00 |
| 2012-09-30 | 2.25 | 0 | 0.00 |
| 2012-06-30 | 6.25 | 0 | 0.00 |
| 2012-03-31 | 6.75 | 0 | 0.00 |
| 2011-12-31 | 1.13 | 0 | 0.00 |
| 2011-03-31 | 28.13 | 0 | 0.00 |
| 2010-12-31 | 56.25 | 0 | 0.00 |
| 2010-09-30 | 84.38 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.502B | $0.234B |
| TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Stryker (SYK) | United States | $125.123B | 29.97 |
| Medtronic (MDT) | Ireland | $108.470B | 15.36 |
| Boston Scientific (BSX) | United States | $106.878B | 34.04 |
| EssilorLuxottica (ESLOY) | France | $97.379B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.753B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.899B | 27.67 |
| ResMed (RMD) | United States | $31.876B | 29.93 |
| Terumo (TRUMY) | Japan | $25.923B | 36.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.996B | 15.99 |
| Koninklijke Philips (PHG) | Netherlands | $24.906B | 19.29 |
| Baxter (BAX) | United States | $18.734B | 13.37 |
| Insulet (PODD) | United States | $12.214B | 64.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.980B | 23.77 |
| BellRing Brands (BRBR) | United States | $7.521B | 40.44 |
| Lantheus Holdings (LNTH) | United States | $5.178B | 13.04 |
| Haemonetics (HAE) | United States | $4.794B | 24.52 |
| Perrigo (PRGO) | Ireland | $4.444B | 12.71 |
| GN Store Nord (GNNDY) | Denmark | $4.368B | 24.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.43 |
| Envista Holdings (NVST) | United States | $3.265B | 13.48 |
| QuidelOrtho (QDEL) | United States | $2.842B | 10.32 |
| Green Thumb Industries (GTBIF) | United States | $2.777B | 88.00 |
| Neogen (NEOG) | United States | $2.604B | 25.04 |
| ICU Medical (ICUI) | United States | $2.436B | 18.18 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.255B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.961B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.772B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.666B | 48.83 |
| InMode (INMD) | Israel | $1.481B | 7.87 |
| National Vision Holdings (EYE) | United States | $1.402B | 43.66 |
| Owens & Minor (OMI) | United States | $1.395B | 12.14 |
| AdaptHealth (AHCO) | United States | $1.364B | 10.26 |
| Warby Parker (WRBY) | United States | $1.257B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.037B | 0.00 |
| AtriCure (ATRC) | United States | $0.994B | 0.00 |
| MacroGenics (MGNX) | United States | $0.980B | 0.00 |
| Evolus (EOLS) | United States | $0.833B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.817B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.754B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.691B | 14.97 |
| Quanterix (QTRX) | United States | $0.651B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.633B | 14.99 |
| Jin Medical (ZJYL) | China | $0.561B | 0.00 |
| Valneva SE (VALN) | France | $0.537B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.514B | 0.00 |
| PetIQ (PETQ) | United States | $0.502B | 18.73 |
| Surmodics (SRDX) | United States | $0.463B | 29.01 |
| Biote (BTMD) | United States | $0.448B | 4.26 |
| ZimVie (ZIMV) | United States | $0.430B | 26.33 |
| OraSure Technologies (OSUR) | United States | $0.420B | 6.95 |
| Aurora Cannabis (ACB) | Canada | $0.368B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.83 |
| Viemed Healthcare (VMD) | United States | $0.318B | 31.46 |
| Cerus (CERS) | United States | $0.300B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.257B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.09 |
| Veru (VERU) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.216B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.206B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.173B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.172B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.168B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.147B | 74.00 |
| Jushi Holdings (JUSHF) | United States | $0.143B | 0.00 |
| InterCure (INCR) | Israel | $0.142B | 24.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| Cellectar Biosciences (CLRB) | United States | $0.123B | 0.00 |
| MariMed (MRMD) | United States | $0.113B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.110B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.86 |
| Brainsway (BWAY) | Israel | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Chimerix (CMRX) | United States | $0.085B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.066B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.74 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.046B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.51 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.021B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |